Arai T, Hayashi E, Maeda S, Matsubara T, Fujii H, Shinohara K
Nat Commun. 2025; 16(1):1950.
PMID: 40082404
PMC: 11906622.
DOI: 10.1038/s41467-025-57167-0.
Toczyska K, Haq N, Lyu Z, Bewick G, Zhao M, Rosa H
Diabetes Obes Metab. 2024; 26(9):3606-3617.
PMID: 38888050
PMC: 11639051.
DOI: 10.1111/dom.15701.
Cho S
Int J Mol Sci. 2024; 25(4).
PMID: 38396891
PMC: 10889845.
DOI: 10.3390/ijms25042211.
Galal M, Alouch S, Alsultan B, Dahman H, Alyabis N, Alammar S
Int J Mol Sci. 2023; 24(19).
PMID: 37834454
PMC: 10573852.
DOI: 10.3390/ijms241915006.
Shirakawa J
J Diabetes Investig. 2023; 14(6):735-740.
PMID: 36871280
PMC: 10204178.
DOI: 10.1111/jdi.14002.
Ang II Controls the Expression of Mapkap1 by miR-375 and Affects the Function of Islet β Cells.
Lin X, Cheng L, Wan Y, Yan Y, Zhang Z, Li X
Endocr Metab Immune Disord Drug Targets. 2023; 23(9):1186-1200.
PMID: 36748222
PMC: 10514520.
DOI: 10.2174/1871530323666230206121715.
The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta-cell mass.
Liu B, Ruz-Maldonado I, Toczyska K, Olaniru O, Zariwala M, Hopkins D
Diabetes Obes Metab. 2022; 24(10):2038-2050.
PMID: 35676820
PMC: 9545812.
DOI: 10.1111/dom.14791.
Maintaining Effective Beta Cell Function in the Face of Metabolic Syndrome-Associated Glucolipotoxicity-Nutraceutical Options.
McCarty M, DiNicolantonio J
Healthcare (Basel). 2022; 10(1).
PMID: 35052168
PMC: 8775473.
DOI: 10.3390/healthcare10010003.
Intercellular Communication in the Islet of Langerhans in Health and Disease.
Ng X, Chung Y, Piston D
Compr Physiol. 2021; 11(3):2191-2225.
PMID: 34190340
PMC: 8985231.
DOI: 10.1002/cphy.c200026.
Functional maturation of immature β cells: A roadblock for stem cell therapy for type 1 diabetes.
Sun Z, Yu T, Jiang F, Wang W
World J Stem Cells. 2021; 13(3):193-207.
PMID: 33815669
PMC: 8006013.
DOI: 10.4252/wjsc.v13.i3.193.
Integrin and autocrine IGF2 pathways control fasting insulin secretion in β-cells.
Arous C, Mizgier M, Rickenbach K, Pinget M, Bouzakri K, Wehrle-Haller B
J Biol Chem. 2020; 295(49):16510-16528.
PMID: 32934005
PMC: 7864053.
DOI: 10.1074/jbc.RA120.012957.
Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus.
Rachdaoui N
Int J Mol Sci. 2020; 21(5).
PMID: 32150819
PMC: 7084909.
DOI: 10.3390/ijms21051770.
Differential expression and release of exosomal miRNAs by human islets under inflammatory and hypoxic stress.
Saravanan P, Vasu S, Yoshimatsu G, Darden C, Wang X, Gu J
Diabetologia. 2019; 62(10):1901-1914.
PMID: 31372667
DOI: 10.1007/s00125-019-4950-x.
Insulin Signaling Regulates the FoxM1/PLK1/CENP-A Pathway to Promote Adaptive Pancreatic β Cell Proliferation.
Shirakawa J, Fernandez M, Takatani T, El Ouaamari A, Jungtrakoon P, Okawa E
Cell Metab. 2017; 25(4):868-882.e5.
PMID: 28286049
PMC: 5382039.
DOI: 10.1016/j.cmet.2017.02.004.
Nuclear Export of FoxO1 Is Associated with ERK Signaling in β-Cells Lacking Insulin Receptors.
Mezza T, Shirakawa J, Martinez R, Hu J, Giaccari A, Kulkarni R
J Biol Chem. 2016; 291(41):21485-21495.
PMID: 27535223
PMC: 5076820.
DOI: 10.1074/jbc.M116.735738.
Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance.
Xu E, Schwab M, Marette A
Rev Endocr Metab Disord. 2013; 15(1):79-97.
PMID: 24264858
DOI: 10.1007/s11154-013-9282-4.
Minireview: intraislet regulation of insulin secretion in humans.
Rutter G, Hodson D
Mol Endocrinol. 2013; 27(12):1984-95.
PMID: 24243488
PMC: 5426601.
DOI: 10.1210/me.2013-1278.
Nupr1 deletion protects against glucose intolerance by increasing beta cell mass.
Barbosa-Sampaio H, Liu B, Drynda R, Rodriguez de Ledesma A, King A, Bowe J
Diabetologia. 2013; 56(11):2477-86.
PMID: 23900510
DOI: 10.1007/s00125-013-3006-x.
Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function.
Wang C, Li X, Mu K, Li L, Wang S, Zhu Y
Diabetologia. 2013; 56(9):1999-2009.
PMID: 23793716
PMC: 4556236.
DOI: 10.1007/s00125-013-2971-4.
Npas4 is a novel activity-regulated cytoprotective factor in pancreatic β-cells.
Sabatini P, Krentz N, Zarrouki B, Westwell-Roper C, Nian C, Uy R
Diabetes. 2013; 62(8):2808-20.
PMID: 23656887
PMC: 3717850.
DOI: 10.2337/db12-1527.